Clinical trial
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
NCT03401307 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
- Lead sponsor
- University of Southern Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- December 1, 2020
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
central nervous system lesion, drug effect, genetic disease, multiple sclerosis, neurodegeneration, neurologic deficits, neurophysiologic abnormality, peripheral nervous system problem